The introduction of white biotechnology or industrial biotechnology in the pharmaceutical sector is gradually gaining a greater height each day. Within this area, biotransformations, meaning the introduction of applied biocatalysis in organic chemical processes is an excellent complement to conventional synthetic drugs.
This stems from the high stereo and
regioselectivity inherent in the use of biocatalysts (biological systems such as whole cells (fungi, yeasts, bacteria) or isolated enzymes, which are able to discriminate a specific and selective way only one of the possible
isomers of a
racemic mixture, achieving the desired product form
enantiopura.
Click to continue »
